Invest to protect: the role of diagnostics for NCDs
Sparking conversations around diagnostics for non-communicable diseases during the Global Week for Action on NCDs (5–11 September 2022)
Despite evidence demonstrating the health, economic, and development value of screening, detection, and management of non-communicable diseases (NCDs), many people, especially in low- and middle-income countries (LMICs), still lack access to NCD diagnostics.
We have been actively working on increasing access to diagnostics for NCDs in LMICs and will officially launch our NCD programme in September during the Global Week for Action on NCDs.
To mark this launch, we are bringing together leaders, experts, and advocates to explore the multiple facets of diagnostics for NCDs in LMICs, through a series of four coffee conversation videos, a live webinar discussion, and a Twitter chat immediately following the webinar.
5–8 September 2022 at 12:00 CEST | Videos (4x releases)
1. The role of diagnostics to help meet targets for diabetes and cervical cancer (Monday 5 September)
- Bente Mikkelsen (WHO) & Sergio Carmona (FIND)
2. Market barriers to NCD diagnostics innovation for LMICs (Tuesday 6 September)
- James Hazel (Access to Medicine Foundation) & Sanjay Sarin (FIND)
3. Patient-centric & integrated diagnostics approaches for NCDs and infectious diseases (Wednesday 7 September)
- Fifa Rahman (Access to COVID-19 Tools (ACT) Accelerator communities representative) & Lejla Druskic (Nurse, T1D, Advocate, Consultant)
4. Sustainable financing for NCDs (Thursday 8 September)
- Kara Hanson (London School of Hygiene & Tropical Medicine, Chair of The Lancet Global Health Commission on financing primary healthcare) & Bill Rodriguez (FIND)
9 September 2022, 14:00–14:45 CEST
9 September 2022, immediately following the live webinar
Twitter chat to reflect on the discussions and perspectives shared during the week. Join the chat using #NCDsDiagnostics.